 |
| ‘±EΥ°± γςiJpκW |
| → pκWCfbNX |
| y s z |
| t1/2 ihalf-life periodj ΌΈϊ |
| TDC iTailored Dose Chemotherapyj ―Εεp±Β\ΚiMRDj |
| TDM iTherapeutic drug monitoringj ‘±ς¨j^O |
| TLO iTechnology Licensing Organizationj ZpΪ]@Φ |
| Tmax imaximum drug concentration timej ΕZxBΤ |
| ίι^Wv |
|
| → pκWCfbNX |